Crossmark

Factors associated with long-term persistence of rituximab in rheumatoid arthritis in clinical practice: RITAR Study

Crossref DOI link: https://doi.org/10.1016/j.medcle.2019.09.006

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cañamares Orbis, Iciar

Merino Meléndez, Leticia

Llorente Cubas, Irene

Benedí González, Juana

García-Vicuña, Rosario

Morell Baladrón, Alberto

González-Álvaro, Isidoro

Ramírez Herraiz, Esther
Funding

Funding for this research was provided by:

Carlos III Health Institute (PIE13/0041, RD16/0012/0011, PI18)

European Regional Development Fund
License Information

Text and Data Mining valid from 2020-07-01
More Information

This article is maintained by: Elsevier

Article Title: Factors associated with long-term persistence of rituximab in rheumatoid arthritis in clinical practice: RITAR Study

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2019.09.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2019.09.021

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. All rights reserved.